Tocilizumab provides dual benefits in treating immune checkpoint inhibitor-associated arthritis and preventing relapse during ICI rechallenge: the TAPIR study
Preprint in medRxiv (July 2024)
The most recent citing publications are shown below. View all 62 publications that cite this research output on Dimensions.
Preprint in medRxiv (July 2024)
Article in Alimentary Pharmacology & Therapeutics (April 2024)
Article in Gastroenterología y Hepatología (English Edition) (April 2024)